Results for "Inexpensive medicines https://simplemedrx.top"
HDA Recognizes Supply Chain Innovation, Leadership Through 2025 Distribution Management Awards
In early March, the Healthcare Distribution Alliance (HDA) honored several industry leaders and innovators as part of the association’s annual Distribution Management Conference and Expo in Tampa, Florida.
HDA Research Foundation Recognizes Craig Cowman of Cardinal Health With Nexus Award
The HDA Research Foundation honored Craig Cowman, Executive Vice President of Biopharma Solutions and Strategic Sourcing for Cardinal Health, Inc., with the 2025 Nexus Award for Lifetime Achievement. The award was presented last night at the Healthcare Distribution Alliance’s (HDA) Business and Leadership Conference in Orlando.
Specialty Distributors Serve a Range of Healthcare Providers
New benchmarking data released today by the HDA Research Foundation reveal the continued efficiency and reliability that HDA specialty distributors deliver to providers treating patients with chronic, complex or rare diseases. As illustrated in the 14th edition of Specialty Pharmaceutical Distribution Facts Figures and Trends, a typical HDA-member specialty distributor delivered products to approximately 56,000 provider ship-to points daily in 2021.
HDA Research Foundation Recognizes Former Cardinal Health CEO Mike Kaufmann with Nexus Award for Lifetime Achievement
The HDA Research Foundation honored Mike Kaufmann, former CEO of Cardinal Health, with the 2023 Nexus Award for Lifetime Achievement. The Nexus Award, the healthcare distribution industry’s highest individual achievement, was presented last night at the Healthcare Distribution Alliance’s Business and Leadership Conference in Colorado Springs.
HDA Research Foundation Explores Challenges and Opportunities of Cold Chain Product Distribution
A new publication released by the HDA Research Foundation and Envision Pharma Group — The Future of the U.S. Pharmaceutical Cold Chain — offers strategies to address the remarkable growth of temperature-sensitive products in the healthcare ecosystem — a product class that, as noted in the report, has outpaced non-cold chain therapies by 21 percent between 2018 and 2024.